Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

NCT04677569 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

425

Enrollment

INDUSTRY

Sponsor class

Conditions

Mycobacterium Infections, Nontuberculous

Interventions

DRUG: ALIS
DRUG: Azithromycin
DRUG: Ethambutol
DRUG: ELC (matching placebo for ALIS)

Sponsor

Insmed Incorporated